NL-OMON33438
Completed
Not Applicable
*Acute neurocognitive and behavioural effects of Magnetic Resonance Imaging related Time varying electromagnetic fields induced by body motion* - Acute neurocognitive and behavioural effects of MRI related EMF
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- gezonde vrijwilligers
- Sponsor
- niversiteit Utrecht
- Enrollment
- 30
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •men and women
- •between 18 and 65 years
Exclusion Criteria
- •Vestibular dysfunction
- •MRI incompatible volunteers
- •Neurological or psychiatric disorders (past or present)
- •Drug use in the last 4 week (except of contraception)
- •see pp 20 of protocol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
*Acute neurocognitive and vestibular effects of Magnetic Resonance Imaging related magnetic fields*gezonde vrijwilligershealthy volunteersNL-OMON37345niversiteit Utrecht36
Completed
Phase 3
A study of the acute cognitive and neurocognitive effects of Panax Quinquefolius (American Ginseng) in middle aged volunteers.Cognitive FunctionGlucoregulatory FunctionAlternative and Complementary Medicine - Other alternative and complementary medicineMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12610000849099aturex50
Active, not recruiting
Not Applicable
Study of CABG outcomes on and off-pump (SCOOP)Coronary artery diseaseCardiovascular - Other cardiovascular diseasesACTRN12605000388617The Sir Charles Gairdner Foundation for Advanced Medical Research provided competitive funding.100
Recruiting
Phase 2
A study of effects on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's diseaseCognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's diseasePericarp mangosteen extract, Alzheimer'TCTR20170509001Department for Development of Thai Traditional and Alternative Medicine, Ministry of Public Health180
Recruiting
Phase 1
ong-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT)Tuberous sclerosis complex (TSC)MedDRA version: 21.0Level: LLTClassification code: 10045138Term: Tuberous sclerosis Class: 10010331Therapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]CTIS2022-502332-39-00Heidelberg University Hospital AöR60